Jack Prior delivering a plenary talk at the Pharma Manufacturing World Summit 2025

I work at the interfaces of biologics manufacturing. Between development and manufacturing, data science and manufacturing science. Today that work is mostly about AI. Getting the data ready is the way in, and agentic AI is finally making it real.

Nearly thirty years of biologics CMC work have taught me that manufacturing excellence comes down to how well we monitor, understand, and control process variability. At Sanofi and Genzyme I have led manufacturing science organizations of up to 50 people, responsible for scale-up, technology transfer, continued process verification, cGMP production support, and critical manufacturing investigations. A decade of that was on the front line in a cGMP plant.

I started working with AI on biologics problems at MIT nearly forty years ago. My doctorate used nonlinear data reconciliation for troubleshooting. Since then I have followed these methods, assessed them, and looked for the right place to apply them. For most of that time the data was too thin and the wrangling too onerous. Agentic AI is finally changing both.

My current role is Head of MSAT Process Monitoring and Data Science/AI Strategy at Sanofi, working across a global biologics network. Three Sanofi Global Innovation Awards came along the way. Board service includes the PDA Science Advisory Board, as an AI expert, the MIT Leaders for Global Operations Governing Board, and the organizing committee of AIChE's PD2M conference. My Sc.D. in chemical engineering is from MIT. My B.S. is from the University of Connecticut, where honors included being named Big East Scholar-Athlete of the Year and later induction into the Academy of Distinguished Engineers.

Process Monitoring AI Projects

Two open efforts I am building to move process monitoring toward AI: one to measure whether the data is ready, the other to test the AI before it touches real data.

BioMetre Readiness

BioMetre

A framework that scores how ready an organization's data is for AI, turning a vague question into a number you can track and improve. It anchors the "Are We There Yet?" digital maturity model I present, and I am working to establish it as an industry benchmark.

AI-mAb Build and test

AI-mAb

An open simulator that generates realistic biologics process data, so AI tools can be developed and stress-tested without waiting on scarce or proprietary datasets. Non-proprietary and available to the field.

Talks and media

"Your talk was super educational. You really are the OG of AI for bioprocess." Richard C. Willson, Huffington-Woestemeyer Professor of Chemical and Biomolecular Engineering, University of Houston
Bioprocessing Unfiltered podcast

Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis

Panel episode, hosted by Maximilian Krippl, with Andrea Arsiccio, Ayca Cetinkaya, and Mario P. Pereira. Recorded at Bioprocessing Summit Europe, Barcelona. Bioprocessing Unfiltered, August 2026.

▶ Listen to episode ▶ Watch on YouTube
2026 ISPE AI in Life Sciences Summit, Boston

Regulatory Panel on AI Guidance

Panelist, with FDA and MHRA. ISPE AI Life Sciences Summit, Boston, June 2026.

LinkedIn post Event page
Bioprocessing Summit Europe 2026 plenary keynotes: Konstantin Konstantinov and Jack Prior

Process Data Readiness for AI in Biologics Manufacturing

Plenary keynote. Cambridge Healthtech Institute Bioprocessing Summit Europe, Barcelona.

LinkedIn post
Bioprocessing Unfiltered podcast

Bioprocessing Unfiltered Podcast

With William Whitford. Cambridge Healthtech Institute.

▶ Listen to episode LinkedIn post
Are We There Yet — Pharma Manufacturing World Summit 2025

Are We There Yet?

Recorded plenary talk. Pharma Manufacturing World Summit 2025.

▶ Watch on Vimeo LinkedIn post
PDA Week 2026 interview with Richard Jaenisch

PDA Week 2026 Interview

Two segments with Richard Jaenisch.

▶ Part 1: The Next Wave of Pharma AI ▶ Part 2: Measuring Data Readiness of AI
Generis PMOS panel announcement: The Innovation Imperative, Jack Prior

The Innovation Imperative: Driving Change with Digital Tools and AI

Panelist, with Mark Hill, Karin Shanahan, and Joseph Horvath. American Pharma Manufacturing and Outsourcing Summit, Boston, November 2025.

LinkedIn post
AIChE PD2M organizing committee roster including Jack Prior

AIChE PD2M Conference

Organizing committee. At PD2M, hosted at Amgen, introduced former intern Jason Kelly, CEO of Ginkgo Bioworks, for his keynote on autonomous labs.

LinkedIn post
Jack Prior presenting at the National Academy of Sciences, February 2020

Opportunities and Challenges in Biologics Manufacturing Process Data Analytics Innovation

National Academy of Sciences, "Innovations in Pharmaceutical Manufacturing" workshop, Washington DC, February 2020.

An invited talk at a National Academies workshop convened to inform a committee writing a report for FDA on process data analytics technologies expected in biologics manufacturing.

▶ Watch on Vimeo Slides (PDF)
Contact Email LinkedIn